QGEN Qiagen N.V.
$42.50▲ +0.88%
Healthcare
Other
After hours
$42.50▲ +0.09%
Sep 11, 4:00 PM ET
Volume 1.11M
Avg Volume (10D) 1.64M
Key Metrics & Fundamentals
Market Cap
$8.78B
P/E Ratio
21.6
Div Yield
0.83%
52W Range
32.53 - 57.82
% vs 50 MA
0.86%
% vs 200 MA
-0.40%
RSI-14
48.3
MACD Histogram
-0.2500
Beta (1Y vs SPY)
0.39
Free Cash Flow
$157.32M
Gross Rev
$535.04M
Gross Profit
$340.39M
EBITDA
$201.93M
COGS
$194.65M
Operating Exp
$199.54M
Operating Income
$140.85M
EBIT
$140.85M
Pretax Income
$132.11M
Net Income
$103.40M
EPS (Diluted)
0.50
Price & Volume History
Loading chart…
Recent News

Transcriptome Sequencing Market - Global Forecast to 2035; Bulk RNA-Seq Maintains Its Technology Market Lead
GlobeNewswire · Sep 10, 2026 11:03 AM
UBS Adjusts Price Target on QIAGEN to $47 From $52, Keeps Neutral Rating
MT Newswires · Sep 9, 2026 1:29 PM

ILMN Stock Keeps Climbing. Should You Climb On?
Trefis · Sep 8, 2026 7:37 PM

Qiagen (QGEN) Beat Q2 Estimates And Reaffirmed Outlook, Is It Still Below Fair Value?
Simply Wall St. · Sep 5, 2026 9:06 PM

How Qiagen’s New Automation Platform, CEO Transition and Q2 Beat Will Impact Qiagen (QGEN) Investors
Simply Wall St. · Sep 5, 2026 7:06 PM

Qiagen (QGEN) Up 5.1% Since Last Earnings Report: Can It Continue?
Zacks · Sep 4, 2026 3:30 PM

Global Multiplex Assays Market 2026 Edition - Consumables Dominate Multiplex Assays with 68% Market Share
GlobeNewswire · Sep 4, 2026 9:48 AM

Plant Virome Diagnostics Outlook 2026-2030 Featuring Profiles of Illumina, Thermo Fisher Scientific and Qiagen
GlobeNewswire · Sep 1, 2026 11:21 AM

TXG Stock Down Despite Patent Verdict Win Against Parse Biosciences
Zacks · Aug 31, 2026 5:12 PM

Could Qiagen (QGEN) Stock Win as Its FDA Clearance Opens a New Diagnostics Market?
Insider Monkey · Aug 28, 2026 8:33 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See QGEN's money flow as a full page
Social Sentiment
No Reddit posts found for QGEN.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.